Masked hypertension and neonatal outcome in high-risk pregnancies.


Journal

Journal of human hypertension
ISSN: 1476-5527
Titre abrégé: J Hum Hypertens
Pays: England
ID NLM: 8811625

Informations de publication

Date de publication:
01 2023
Historique:
received: 11 10 2021
accepted: 09 12 2021
revised: 29 11 2021
pubmed: 17 1 2022
medline: 13 1 2023
entrez: 16 1 2022
Statut: ppublish

Résumé

We previously showed that masked hypertension is a frequent finding in high-risk pregnancies and a strong predictor of preeclampsia/eclampsia. However, neonatal consequences of masked hypertension have not been deeply analyzed. Consequently, the aim of this study was to determine if masked hypertension is a risk factor for poor neonatal outcome. We evaluated a cohort of 588 high-risk pregnant women (29 ± 7 years old with 27 ± 6 weeks of gestation at blood pressure evaluation); 22.1%, 8.5%, 2.9%, and 2.6% had history of hypertension, diabetes, collagen diseases and chronic renal disease, respectively. According to the data of office and ambulatory blood pressures monitoring, women was classified as normotension (61.7%), white-coat hypertension (5.4%), masked hypertension (21.6%) and sustained hypertension (11.2%) respectively. Compared to normotension, all neonatal outcomes were worst in women with masked hypertension; neonates had lower mean birth weight (2577 (842) vs. 3079 (688) g, P < 0.001), higher prevalence of very low (12.1% vs 2.0%, P = .002) and extremely low birth weight (4.3% vs 0%, P < 0.001), and low one-minute APGAR score (7.8% vs 1.8%, P < 0.001). Furthermore, 14.2% needed admission to neonatal intensive care unit (NICE) (P = 0.001). Compared with normotension the risk for poor the combined neonatal outcome (admission to NICE plus still born) was significantly higher in masked hypertension (adjusted OR 2.58 95% CI 1.23-5.40) but not in white-coat hypertension (adjusted OR 0.41 95% CI 0.05-3.12). In conclusion, in high-risk pregnancies, masked hypertension was a strong and independent predictor for poor neonatal outcomes.

Identifiants

pubmed: 35034090
doi: 10.1038/s41371-021-00649-7
pii: 10.1038/s41371-021-00649-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-41

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels, J., et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323–e333. https://doi.org/10.1016/S2214-109X(14)70227-X .
doi: 10.1016/S2214-109X(14)70227-X
Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS One. 2014;9:e113715. https://doi.org/10.1371/journal.pone.0113715 .
doi: 10.1371/journal.pone.0113715
Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, et al. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine-Units. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol. 2002;186:422–6. https://doi.org/10.1067/mob.2002.120280 . Erratum in: Am J Obstet Gynecol. 2003 Jul;189:244. PMID: 11904601.
doi: 10.1067/mob.2002.120280
Yücesoy G, Ozkan S, Bodur H, Tan T, Calişkan E, Vural B, et al. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol Obstet. 2005;273:43–9. https://doi.org/10.1007/s00404-005-0741-3 .
doi: 10.1007/s00404-005-0741-3
Gofton EN, Capewell V, Natale R, Gratton RJ. Obstetrical intervention rates and maternal and neonatal outcomes of women with gestational hypertension. Am J Obstet Gynecol. 2001;185:798–803. https://doi.org/10.1067/mob.2001.117314 .
doi: 10.1067/mob.2001.117314
Steer PJ, Little MP, Kold-Jensen T, Chapple J, Elliott P. Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ. 2004;329:1312. https://doi.org/10.1136/bmj.38258.566262.7C .
doi: 10.1136/bmj.38258.566262.7C
Brown MA, Robinson A, Jones M. The white coat effect in hypertensive pregnancy: much ado about nothing?. Br J Obstet Gynaecol. 1999;106:474–80. https://doi.org/10.1111/j.1471-0528.1999.tb08301.x .
doi: 10.1111/j.1471-0528.1999.tb08301.x
Salazar MR, Espeche WG, Balbín E, Leiva Sisnieguez CE, Leiva Sisnieguez BC, Stavile RN, et al. Office blood pressure values and the necessity of out-of-office measurements in high-risk pregnancies. J Hypertens. 2019;37:1838–44. https://doi.org/10.1097/HJH.0000000000002140 .
doi: 10.1097/HJH.0000000000002140
Liro M, Gasowski J, Wydra D, Grodzicki T, Emerich J, Narkiewicz K. Twenty-four-hour and conventional blood pressure components and risk of preterm delivery or neonatal complications in gestational hypertension. Blood Press. 2009;18:36–43. https://doi.org/10.1080/08037050902836753 .
doi: 10.1080/08037050902836753
Eguchi K, Ohmaru T, Ohkuchi A, Hirashima C, Takahashi K, Suzuki H, et al. Ambulatory BP monitoring and clinic BP in predicting small-for-gestational-age infants during pregnancy. J Hum Hypertens. 2016;30:62–7. https://doi.org/10.1038/jhh.2015.20 .
doi: 10.1038/jhh.2015.20
Waugh J, Perry IJ, Halligan AW, De Swiet M, Lambert PC, Penny JA, et al. Birth weight and 24-hour ambulatory blood pressure in nonproteinuric hypertensive pregnancy. Am J Obstet Gynecol. 2000;183:633–7. https://doi.org/10.1067/mob.2000.106448 .
doi: 10.1067/mob.2000.106448
Johnson S, Liu B, Kalafat E, Thilaganathan B, Khalil A. Maternal and perinatal outcomes of white coat hypertension during pregnancy: a systematic review and meta-analysis. Hypertension. 2020;76:157–66. https://doi.org/10.1161/HYPERTENSIONAHA.119.14627 .
doi: 10.1161/HYPERTENSIONAHA.119.14627
Salazar MR, Espeche WG, Leiva Sisnieguez BC, Balbín E, Leiva Sisnieguez CE, Stavile RN, et al. Significance of masked and nocturnal hypertension in normotensive women coursing a high-risk pregnancy. J Hypertens. 2016;34:2248–52. https://doi.org/10.1097/HJH.0000000000001067 .
doi: 10.1097/HJH.0000000000001067
Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:I2381.
doi: 10.1136/bmj.l2381
Rodrigues Â, Barata C, Marques I, Almeida MC. Diagnosis of white coat hypertension and pregnancy outcomes. Pregnancy Hypertens. 2018;14:121–4. https://doi.org/10.1016/j.preghy.2018.08.452 .
doi: 10.1016/j.preghy.2018.08.452
Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat hypertension during pregnancy. BJOG. 2005;112:601–6. https://doi.org/10.1111/j.1471-0528.2004.00516.x .
doi: 10.1111/j.1471-0528.2004.00516.x
Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209:544.e1–544.e12. https://doi.org/10.1016/j.ajog.2013.08.019.
doi: 10.1016/j.ajog.2013.08.019.
Sala ME, Romero MF, Romero A, Fasano MV, Varea AM, Carrera P, et al. Neurodevelopmental assessment of infants born to mothers with hypertensive disorder of pregnancy at six months of age. J Dev Orig Health Dis. 2021;20:1–7. https://doi.org/10.1017/S204017442100026X .
doi: 10.1017/S204017442100026X
Lv LJ, Ji WJ, Wu LL, Miao J, Wen JY, Lei Q, et al. Thresholds for ambulatory blood pressure monitoring based on maternal and neonatal outcomes in late pregnancy in a southern Chinese population. J Am Heart Assoc. 2019;8:e012027.
doi: 10.1161/JAHA.119.012027
Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ., et al. 2017 ACC/AHA/ AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–248. Published erratum appears in J Am Coll Cardiol 2018;71:2275–9.
doi: 10.1016/j.jacc.2017.11.006
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy. Obstet Gynecol. 2019;133:e26–e50.
Salazar MR, Espeche WG, Leiva Sisnieguez CE, Minetto J, Balbín E, Soria A, et al. Nocturnal hypertension and risk of developing early-onset preeclampsia in high-risk pregnancies. Hypertens Res. 2021. https://doi.org/10.1038/s41440-021-00740-z .

Auteurs

Martin R Salazar (MR)

Unidad de Enfermedades Cardiometabólicas, Servicio de Clínica Médica, Hospital Gral. San Martín, La Plata, Argentina. salazarlandea@gmail.com.
Facultad de Ciencias Médicas, UNLP, La Plata, Argentina. salazarlandea@gmail.com.

Walter G Espeche (WG)

Unidad de Enfermedades Cardiometabólicas, Servicio de Clínica Médica, Hospital Gral. San Martín, La Plata, Argentina.
Facultad de Ciencias Médicas, UNLP, La Plata, Argentina.

Carlos E Leiva Sisnieguez (CE)

Unidad de Enfermedades Cardiometabólicas, Servicio de Clínica Médica, Hospital Gral. San Martín, La Plata, Argentina.
Facultad de Ciencias Médicas, UNLP, La Plata, Argentina.

Paola L Juliano (PL)

Servicio de Neonatología, Hospital Gral. San Martín, La Plata, Argentina.

María V Vulcano (MV)

Servicio de Neonatología, Hospital Gral. San Martín, La Plata, Argentina.

Laura Sanchez Caro (L)

Servicio de Neonatología, Hospital Gral. San Martín, La Plata, Argentina.

Julián Minetto (J)

Unidad de Enfermedades Cardiometabólicas, Servicio de Clínica Médica, Hospital Gral. San Martín, La Plata, Argentina.
Facultad de Ciencias Médicas, UNLP, La Plata, Argentina.

Eduardo Balbín (E)

Facultad de Ciencias Médicas, UNLP, La Plata, Argentina.

Horacio A Carbajal (HA)

Facultad de Ciencias Médicas, UNLP, La Plata, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH